GeneDx Holdings Corp. WGS
Slide the table for earlier years · "·" marks a figure not available in our data for that year.
Growth
Revenue compounded at +19.0% a year over the five years to FY2025.
Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.
Profitability
Each USD of equity lost 8 cents this year.
The 7-year record
EPS, diluted, dividend per share and shares outstanding are shown without shading, and a vertical line marks the year the share count changed — the series crosses a large, unexplained change in share count, so the years on either side are not on a comparable scale.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Revenue $B | 0.4 | 0.3 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 |
| Operating income $B | −0.0 | −0.0 | −0.2 | −0.7 | −0.4 | −0.2 | −0.0 |
| EBITDA $B | −0.0 | −0.0 | −0.2 | −0.6 | −0.4 | −0.2 | −0.0 |
| Income tax $B | −0.0 | −0.0 | −0.0 | −0.0 | 0.0 | 0.0 | 0.0 |
| Net income $B | −0.0 | −0.1 | −0.2 | −0.5 | −0.2 | −0.2 | −0.0 |
| Free cash flow $B | 0.0 | −0.0 | −0.2 | −0.3 | −0.2 | −0.1 | −0.0 |
| EPS, diluted $ | −0.73 | ◌ | ◌ | ◌ | −2.27 | −47036.00 | ◌ |
| Dividend / sh $ | ◌ | ◌ | ◌ | ◌ | ◌ | ◌ | ◌ |
| Payout % — not applicable: no dividend | — | — | — | — | — | — | — |
| ROE % | −7.6 | −22.1 | −73.0 | −171.1 | — | — | — |
| Shares out B | 0.03 | 0.03 | 0.03 | 0.01 | ◌ | ◌ | ◌ |
Slide the table for earlier years. "—" not applicable · "◌" not available in our data.
Company facts, as filed
Reconciled in 7 of the 7 fiscal years we could check. 26 checks were skipped: the balance sheet is not tagged before 2020. 12 checks were skipped: EPS is not tagged before 2019. 12 checks were skipped: revenue is not tagged before 2019.